DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID ▼ | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | AKR1A1 | 10327 | aldo-keto reductase family 1 member A1 | P14550 |
C0023895 | Liver diseases | AKR1A1 | 10327 | aldo-keto reductase family 1 member A1 | P14550 |
C3495676 | Anorectal Malformations | AKR1A1 | 10327 | aldo-keto reductase family 1 member A1 | P14550 |
C0278996 | Malignant Head and Neck Neoplasm | AKR1A1 | 10327 | aldo-keto reductase family 1 member A1 | P14550 |
C0278595 | Adult Fibrosarcoma | AKR1A1 | 10327 | aldo-keto reductase family 1 member A1 | P14550 |
C0085409 | Polyendocrinopathies, Autoimmune | AKR1A1 | 10327 | aldo-keto reductase family 1 member A1 | P14550 |
C0023891 | Liver Cirrhosis, Alcoholic | AKR1A1 | 10327 | aldo-keto reductase family 1 member A1 | P14550 |
C0149931 | Migraine Disorders | AKR1A1 | 10327 | aldo-keto reductase family 1 member A1 | P14550 |
C1168401 | Squamous cell carcinoma of the head and neck | AKR1A1 | 10327 | aldo-keto reductase family 1 member A1 | P14550 |
C0751688 | Malignant Squamous Cell Neoplasm | AKR1A1 | 10327 | aldo-keto reductase family 1 member A1 | P14550 |
C0031117 | Peripheral Neuropathy | AKR1A1 | 10327 | aldo-keto reductase family 1 member A1 | P14550 |
C0162309 | Adrenoleukodystrophy | AKR1A1 | 10327 | aldo-keto reductase family 1 member A1 | P14550 |
C0004114 | Astrocytoma | AKR1A1 | 10327 | aldo-keto reductase family 1 member A1 | P14550 |
C0029456 | Osteoporosis | AKR1A1 | 10327 | aldo-keto reductase family 1 member A1 | P14550 |
C0018799 | Heart Diseases | AKR1A1 | 10327 | aldo-keto reductase family 1 member A1 | P14550 |
C0041834 | Erythema | AKR1A1 | 10327 | aldo-keto reductase family 1 member A1 | P14550 |
C1332986 | Childhood Osteosarcoma | AKR1A1 | 10327 | aldo-keto reductase family 1 member A1 | P14550 |
C1260386 | Glucocorticoid-remediable aldosteronism | AKR1A1 | 10327 | aldo-keto reductase family 1 member A1 | P14550 |
C0684249 | Carcinoma of lung | AKR1A1 | 10327 | aldo-keto reductase family 1 member A1 | P14550 |
C0010054 | Coronary Arteriosclerosis | AKR1A1 | 10327 | aldo-keto reductase family 1 member A1 | P14550 |
C0003969 | Ascorbic Acid Deficiency | AKR1A1 | 10327 | aldo-keto reductase family 1 member A1 | P14550 |
C0023903 | Liver neoplasms | AKR1A1 | 10327 | aldo-keto reductase family 1 member A1 | P14550 |
C0242379 | Malignant neoplasm of lung | AKR1A1 | 10327 | aldo-keto reductase family 1 member A1 | P14550 |
C0595989 | Carcinoma of larynx | AKR1A1 | 10327 | aldo-keto reductase family 1 member A1 | P14550 |
C0017921 | Glycogen storage disease type II | AKR1A1 | 10327 | aldo-keto reductase family 1 member A1 | P14550 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024